This page shows the latest Opioid drug news and features for those working in and with pharma, biotech and healthcare.
The FDA has set a date of 7 August to complete its review of the marketing application for the intravenously-administered drug, a mu-opioid receptor agonist which is billed as ... the risk of respiratory and gastrointestinal side effects seen with other
Mallinckrodt’s speciality US generics business – which includes its opioid drug franchise – will file for chapter 11 bankruptcy protection as part of the wide-scale agreement. ... We recognise the opioid crisis is a tremendously complex public
At least 21 US states have rejected an $18bn proposal by the ‘big three’ pharma wholesalers to settle opioid litigation, according to a Wall Street Journal report. ... to negotiating a deal that would “provide relief to communities impacted by the
Verdict closely follows rejection of Nektar’s opioid analgesic. The FDA’s Anesthetic and Analgesic Committee has rejected yet another opioid drug – this time Intellipharmaceutics’ extended-release oxycodone tablet Aximiris. ... Oxycodone is the
Panelists unanimously rejected use of the chronic back pain drug. Nektar Therapeutics has been hit with a unanimous FDA panel rejection of its opioid painkiller, over concerns of drug abuse and ... The application for the drug – NKTR-181 – was
During his time leading the FDA, Sharpless has driven progress on a number of core issues including lowering drug prices and tackling the epidemic of youth use of tobacco products. ... If he does become the agency’s next leader, he will have his hands
More from news
Approximately 1 fully matching, plus 35 partially matching documents found.
Using portraits and quotes from people who use drugs, the campaign urges the community to carry naloxone – a life-saving opioid overdose reversal drug. ... But further than that, we helped to get a life-saving drug into the hands of people who needed
Rising levels of drug use are barbed with the complexities of opioid dependence and wreathed with the unpredictable wildfires of lawsuits. ... It is hardly the easiest climate in which to market an opioid-based drug to treat addiction, while at the same
CAM2038 is an injectable solution that slowly releases buprenorphine – the most common drug used to treat opioid addiction – into the body, eliminating the need for daily dosages as well as the ... Compared with a similar treatment marketed by
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
It will mark the first nationwide effort to talk specifically about opioid overdose prevention and naloxone, a drug that can reverse an opioid overdose – caused by drugs like heroin. ... Naloxone is a lifesaving drug that can reverse an opioid overdose,
Our agency was responsible for the EU launch of OxyContin and the first sublingual formulation of fentanyl, a powerful opioid that is abused by many drug addicts. ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse.
using their state’s Prescription Drug Monitoring Program (PDMP) database before prescribing opioids to a patient. ... After all, having physicians more frequently access these state PMDPs at the point of prescription can go a long way to preventing
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...